
News|Articles|January 21, 2026
Investigation of Separation Conditions and Prep Purification of GLP-1 Receptor Agonist Semaglutide
Author(s)Shimadzu Corporation
The article describes a comprehensive automated prep purification workflow targeting semaglutide, a GLP-1 receptor agonist, using dedicated method development software to automatically optimize a gradient profile and search for conditions that meet the specified separation criteria. This was followed by scale-up to purification scale and streamlined confirmation of the purities of collected fractions using benchtop MALDI-TOF MS.
Trending on LCGC International
1
HPLC-FLD Confirms Aflatoxins in Peanuts, Pistachios
2
Industry Roundup: Shimadzu Debuts GCMS-TQ RX Series, Tackling Helium Shortage and Laboratory Throughput Pressures
3
GC-MS Profiles Nano Garlic and Lemon Oils
4
From Emerging Modalities to R&D Priorities
5
